Rimini Street, Inc.

For the period ended Jun 30, 2026. Filed Jul 30, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Jul 30, 2026

RMNI$5.53+2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

ITEM 1. Financial Statements

Unaudited Condensed Consolidated Balance Sheets

(In thousands, except per share amounts)

	June 30,	December 31,
	2026	2025
ASSETS
Current assets:
Cash and cash equivalents	$123,441	$119,974
Restricted cash, current	342	341
Accounts receivable, net of allowance of $1,802 and $1,443, respectively	91,760	136,866
Deferred contract costs, current	17,579	17,734
Prepaid expenses and other	29,141	25,447
Total current assets	262,263	300,362
Long-term assets:
Restricted cash, noncurrent	784	785
Property and equipment, net of accumulated depreciation and amortization of $24,606 and $23,822, respectively	9,615	10,239
Operating lease right-of-use assets	19,695	21,371
Deferred contract costs, noncurrent	24,064	24,436
Deposits and other	8,717	8,379
Deferred income taxes, net	59,114	57,540
Total assets	$384,252	$423,112
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Current maturities of long-term debt	$—	$4,031
Accounts payable	4,577	5,752
Accrued compensation, benefits and commissions	36,851	39,609
Other accrued liabilities	23,466	24,307
Operating lease liabilities, current	4,355	4,984
Deferred revenue, current	243,059	268,717
Total current liabilities	312,308	347,400
Long-term liabilities:
Long-term debt, net of current maturities	46,575	63,156
Deferred revenue, noncurrent	24,072	18,824
Operating lease liabilities, noncurrent	16,600	18,843
Other long-term liabilities	1,365	1,918
Total liabilities	400,920	450,141
Commitments and contingencies (Note 8)
Stockholders’ deficit:
Preferred stock; $0.0001 par value. Authorized 99,820 (excluding 180 shares of Series A Preferred Stock) no other series has been designated	—	—
Common stock; $0.0001 par value. Authorized 1,000,000 shares; issued and outstanding 93,336 and 91,603 shares, respectively	9	9
Additional paid-in capital	186,907	181,075
Accumulated other comprehensive loss	(4,843)	(5,613)
Accumulated deficit	(197,625)	(201,384)
Treasury stock, at cost; 137 and 137 shares, respectively	(1,116)	(1,116)
Total stockholders' deficit	(16,668)	(27,029)
Total liabilities and stockholders' deficit	$384,252	$423,112

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income

(In thousands, except per share amounts)

	Three Months EndedJune 30,		Six Months EndedJune 30,
	2026	2025	2026	2025
Revenue	$111,075	$104,114	$216,548	$208,318
Cost of revenue	43,378	41,261	86,586	81,931
Gross profit	67,697	62,853	129,962	126,387
Operating expenses:
Sales and marketing	42,743	38,020	81,379	72,275
General and administrative	17,301	16,845	35,151	34,376
Research and development	1,114	—	1,685	—
Reorganization costs	166	722	573	1,184
Litigation costs and related recoveries:
Litigation settlement	—	(36,196)	—	(36,196)
Professional fees and other costs of litigation	—	2,264	—	4,189
Litigation costs and related recoveries, net	—	(33,932)	—	(32,007)
Total operating expenses	61,324	21,655	118,788	75,828
Operating income	6,373	41,198	11,174	50,559
Non-operating income and (expenses):
Interest expense	(1,130)	(1,629)	(2,381)	(3,304)
Other income (expenses), net	(284)	1,232	(1,524)	1,155
Income before income taxes	4,959	40,801	7,269	48,410
Income taxes	(2,561)	(10,543)	(3,510)	(14,802)
Net income	2,398	30,258	3,759	33,608
Other comprehensive income
Foreign currency translation gain (loss)	134	2,230	(188)	2,904
Derivative instrument and other adjustments, net of tax	532	(703)	958	(1,686)
Comprehensive income	$3,064	$31,785	$4,529	$34,826
Net income per share attributable to common stockholders:
Basic	$0.03	$0.33	$0.04	$0.37
Diluted	$0.03	$0.32	$0.04	$0.36
Weighted average number of shares of Common Stock outstanding:
Basic	92,931	92,127	92,364	91,686
Diluted	94,833	94,120	94,398	93,752

Unaudited Condensed Consolidated Statements of Stockholders' Deficit

	Three Months Ended June 30,		Six Months EndedJune 30,
	2026	2025	2026	2025
Common Stock, Shares
Beginning of period	92,133	91,351	91,603	91,120
Exercise of stock options for cash	64	1	188	3
Restricted and performance stock units vested	1,139	1,152	1,545	1,381
End of period	93,336	92,504	93,336	92,504
Total Stockholders' Deficit, beginning of period	$(22,566)	$(63,696)	$(27,029)	$(69,445)
Common Stock, Amount
Beginning of period	9	9	9	9
Exercise of stock options for cash	—	—	—	—
Restricted and performance stock units vested	—	—	—	—
End of period	9	9	9	9
Additional Paid-in Capital
Beginning of period	184,073	180,241	181,075	177,533
Stock based compensation expense	2,660	2,873	5,321	5,575
Exercise of stock options for cash	174	3	511	9
Restricted and performance stock units vested	—	—	—	—
End of period	186,907	183,117	186,907	183,117
Accumulated Other Comprehensive Loss
Beginning of period	(5,509)	(7,698)	(5,613)	(7,389)
Other comprehensive income	666	1,527	770	1,218
End of period	(4,843)	(6,171)	(4,843)	(6,171)
Accumulated Deficit
Beginning of period	(200,023)	(235,132)	(201,384)	(238,482)
Net income	2,398	30,258	3,759	33,608
End of period	(197,625)	(204,874)	(197,625)	(204,874)
Treasury Stock	(1,116)	(1,116)	(1,116)	(1,116)
Total Stockholders' Deficit, end of period	$(16,668)	$(29,035)	$(16,668)	$(29,035)

Unaudited Condensed Consolidated Statements of Cash Flows

	Six Months Ended June 30,
	2026	2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$3,759	$33,608
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	5,321	5,575
Depreciation and amortization	1,999	1,789
Accretion and amortization of debt discount and issuance costs	326	326
Deferred income taxes	(1,654)	10,628
Amortization and accretion related to operating right of use assets	2,678	2,421
Other	37	—
Changes in operating assets and liabilities:
Accounts receivable, net	37,337	31,080
Prepaid expenses, deposits and other	(2,226)	(42,620)
Deferred contract costs	527	2,362
Accounts payable	(1,147)	675
Accrued compensation and other accruals	(8,649)	(6,602)
Deferred revenue	(15,432)	(23,305)
Net cash provided by operating activities	22,876	15,937
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(1,378)	(2,661)
Net cash used in investing activities	(1,378)	(2,661)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on revolving line of credit borrowings	—	(5,000)
Principal payments on term loan borrowings	(20,938)	(1,875)
Principal payments on capital leases	—	(191)
Proceeds from exercise of employee stock options	511	9
Net cash used in financing activities	(20,427)	(7,057)
Effect of foreign currency translation changes	2,396	7,046
Net change in cash, cash equivalents and restricted cash	3,467	13,265
Cash, cash equivalents and restricted cash at beginning of period	121,100	89,222
Cash, cash equivalents and restricted cash at end of period	$124,567	$102,487

Unaudited Condensed Consolidated Statements of Cash Flows, Continued

	Six Months Ended June 30,
	2026	2025
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	$1,997	$2,995
Cash paid for income taxes	2,164	1,900
Cash paid for withholding taxes	2,749	2,144

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.